Japan authorizes its first stem cell therapy to treat Parkinson’s disease
Japan has approved pioneering stem cell therapies for Parkinson’s disease and severe heart failure, with patient availability expected in a few months, according to company and media reports on Friday (6). Sumitomo Pharma confirmed authorization to manufacture and sell Amchepry, its stem-cell-based Parkinson’s treatment. Approval of ReHeart for Heart Regeneration by Cuorips The Japanese Ministry […]
Japan authorizes its first stem cell therapy to treat Parkinson’s disease Read More »









